	Les Charges D'Exploitation		Date
Alaunos Therapeutics	USD 1.19M	428K	2025-09
Alnylam Pharmaceuticals	USD 881.04M	91.16M	2025-09
Alterity Therapeutics Limited	AUD 7.78M	3M	2023-06
Amgen	USD 5.9B	773M	2025-12
Bayer	EUR 10.2B	523M	2025-09
BioCryst Pharmaceuticals	USD -387.89M	33.7M	2025-09
Biogen	USD 1.88B	81.4M	2025-09
BioMarin Pharmaceutical	USD 807.82M	259.3M	2025-09
Cipla	INR 60.98B	1.06B	2025-12
Clal Biotechnology	ILS 5.15M	9.47M	2022-12
Compugen	USD 9.78M	90K	2025-09
CSL	USD 2.87B	2.85B	2025-06
Gilead Sciences	USD 4.26B	95M	2025-09
GlaxoSmithKline	GBP 7.18B	1.42B	2025-12
Grifols	EUR 1.77B	22.04M	2025-09
Ionis Pharmaceuticals	USD 316.9M	4.69M	2025-09
J&J	USD 18.97B	2.38B	2025-12
Karyopharm Therapeutics	USD 61.82M	3.24M	2024-12
Merck	USD 10.16B	558M	2025-12
Novartis	USD 9.86B	115M	2025-09
Omeros	USD 59.16M	20.13M	2024-06
Pfizer	USD 12.91B	79.89B	2025-12
Roche Holding	CHF 21.01B	10.84B	2025-12
Sangamo BioSciences	USD 33.87M	12.89M	2024-06
Sanofi	EUR 10.51B	1.21B	2025-12
Sarepta Therapeutics	USD 462.23M	33.28M	2025-09
Tectonic Therapeutic	USD 21.89M	440K	2025-09
Ultragenyx Pharmaceutical	USD 330.82M	56.44M	2025-09
Vertex Pharmaceuticals	USD 1.84B	27.1M	2025-09

Sangamo BioSciences Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.